about
Perspective of Use of Antiviral Peptides against Influenza VirusThe Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer TherapyTargeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkBGuidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.In vitro interactions between 17β-estradiol and DNA result in formation of the hormone-DNA complexes.Identification of estrogen receptor proteins in breast cancer cells using matrix-assisted laser desorption/ionization time of flight mass spectrometry (Review).Study of linkage between glutathione pathway and the antibiotic resistance of Escherichia coli from patients' swabs.Structural effects and nanoparticle size are essential for quantum dots-metallothionein complex formation.Influence of microbiome species in hard-to-heal wounds on disease severity and treatment duration.Exposure to 17β-Oestradiol Induces Oxidative Stress in the Non-Oestrogen Receptor Invertebrate Species Eisenia fetida.Fully automated two-step assay for detection of metallothionein through magnetic isolation using functionalized γ-Fe2O3 particles.Spatial mapping of metals in tissue-sections using combination of mass-spectrometry and histology through image registrationInfluence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer.Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients.Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomesApoferritin applications in nanomedicine.Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer.Nanotechnologies in protein microarrays.Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?Advanced nanotechnologies in avian influenza: Current status and future trends - A review.Apoferritin as an ubiquitous nanocarrier with excellent shelf life.Carbon dots based FRET for the detection of DNA damage.Amino Acid Profiling of Zinc Resistant Prostate Cancer Cell Lines: Associations With Cancer Progression.Metallothioneins in Prion- and Amyloid-Related Diseases.Electrochemical sensing of etoposide using carbon quantum dot modified glassy carbon electrode.Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.Paramagnetic nanoparticles as a platform for FRET-based sarcosine picomolar detection.3D-printed biosensor with poly(dimethylsiloxane) reservoir for magnetic separation and quantum dots-based immunolabeling of metallothionein.Transport phenomena of nanoparticles in plants and animals/humans.17β-estradiol-containing liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line.Zinc and zinc-containing biomolecules in childhood brain tumors.An enzymatic assay based on luciferase Ebola virus-like particles for evaluation of virolytic activity of antimicrobial peptides.Alternative Synthesis Route of Biocompatible Polyvinylpyrrolidone Nanoparticles and Their Effect on Pathogenic Microorganisms.A two-step protocol for isolation of influenza A (H7N7) virions and their RNA for PCR diagnostics based on modified paramagnetic particles.Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.Nanoparticles Suitable for BCAA Isolation Can Serve for Use in Magnetic Lipoplex-Based Delivery System for L, I, V, or R-rich Antimicrobial Peptides.Magnetic Nanoparticles: From Design and Synthesis to Real World Applications.Flow injection analysis with electrochemical detection for rapid identification of platinum-based cytostatics and platinum chlorides in water.A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin.
P50
Q26780434-8180AB9E-B1D7-4E93-962F-31BBC5BE0286Q28554619-826CA36B-E200-4607-A965-6EFD3BEFBB94Q28818744-1812C326-4158-4DD4-83B7-AF2C5AEB9CB2Q30392564-25ECDAED-CE0C-4823-B350-378A907D07EBQ33364225-52F6CD94-822A-4192-8938-777E7DDB8929Q34086024-BE6875E4-A4FB-4F7D-82AF-5AA247491C28Q35157380-0C2C4506-8163-4ADB-A1BD-8D0ACB2ABA37Q35585474-AA82D579-AE07-4CF8-9A58-69C68BA3DD63Q35713398-72CE2968-E7DC-4F18-BC48-035AC3D20654Q35827717-A16681B5-EE20-4056-BE6F-C4CE952042F5Q35875973-75AB30DB-A258-4D4D-A1E4-9A3F88EF95DDQ36186206-1779E4E7-DD08-4D65-80CB-1535EB1A44C0Q36245291-DD0C593B-8F5F-4551-A954-408F52B89C4EQ36743703-7223771F-4E06-44A3-9DCA-4AE55CAE4140Q37206267-3F6F0695-6924-4053-9E67-86D3C4CCD27CQ37267205-94FF683F-BCA9-4CAE-B658-893A804B4B39Q38269129-5A0A7F0C-96EB-475F-9EFC-42DE765ED154Q38289946-F3915C0D-89B4-41D1-A374-B972F12057C9Q38514458-BBADC0F3-48F8-4EC2-B498-1459046740F7Q38596233-03CDACA1-64A3-4665-9F86-AFE7EA201DB3Q38642075-CA475622-5EAB-4E40-80D5-D5C44F4727E8Q38708389-3B4F9B3D-2872-40ED-8909-59C15418EA7EQ38715970-1B1BE73C-3C76-43DB-A1CF-15841D6CA10AQ38720605-B5D56CD5-8F5B-427A-9B07-C51FE1C0C51EQ38753411-6583F589-202F-41F9-A444-91DAB1B6ED1FQ38793818-8CB37654-D53E-493C-BE04-CB0DB2B7FE9EQ38796386-8D1E5947-4A7C-4AB9-924C-E51AB571B88AQ38902829-BBAA5E72-0151-409D-AEFB-FCBB3C58A0BFQ38904254-120E0000-471A-437D-A3FC-9787BCEF247CQ38922744-D95EE075-97A8-46DB-8014-000FB67FA404Q38936916-3CE607D5-048E-4653-836B-DDF7998FABDDQ38957110-3C8260BF-9DBD-4BCE-93F0-C5760148F9EAQ40075325-5AB258A1-C0BD-4102-90F3-07A2ABF3F8C6Q40413340-88172F56-845C-427A-AA17-9B2BCBFB0B3CQ40775441-DCEF1433-950E-46F4-AAAC-E1A8A9C56EA0Q40871740-4AC91F35-292C-47FE-ADF8-4F455954DD0FQ40967338-7088167E-2D36-4ADB-9CB4-32C37A3BBDE7Q41667081-393D45AA-6569-4996-A7E1-9718CB6D2F0AQ42006450-C9D83318-D2D1-426C-8F47-1C59EA51FCFAQ42116782-8616ED11-423F-46E4-A70D-DA6A682D4877
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zbynek Heger
@ast
Zbynek Heger
@en
Zbynek Heger
@es
Zbynek Heger
@nl
Zbynek Heger
@sl
type
label
Zbynek Heger
@ast
Zbynek Heger
@en
Zbynek Heger
@es
Zbynek Heger
@nl
Zbynek Heger
@sl
prefLabel
Zbynek Heger
@ast
Zbynek Heger
@en
Zbynek Heger
@es
Zbynek Heger
@nl
Zbynek Heger
@sl
P1053
D-1973-2013
P106
P31
P3829
P496
0000-0002-3915-7270